Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial (Q43906420)

27 November 2017

title

Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial (English)

1 reference

27 November 2017

6

1 reference

27 November 2017

7

1 reference

27 November 2017

8

Piero Ruggenenti

1 reference

27 November 2017

5

Annalisa Perna

1 reference

27 November 2017

4

Agustina Anabaya

1 reference

27 November 2017

Raul Plata

1

1 reference

27 November 2017

Arturo Cornejo

series ordinal

2

1 reference

27 November 2017

Carla Arratia

series ordinal

3

1 reference

27 November 2017

Commission on Global Advancement of Nephrology (COMGAN), Research Subcommittee of the International Society of Nephrology

series ordinal

9

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

359

1 reference

27 November 2017

issue

9307

1 reference

27 November 2017

page(s)

663-666

1 reference

Polycythemic responses to hypoxia: molecular and genetic mechanisms of chronic mountain sickness

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

Posttransplant erythrocytosis: an enigma revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

Angiotensin II stimulates proliferation of normal early erythroid progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

Expression of angiotensin II type I receptor on erythroid progenitors of patients with post transplant erythrocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

Association of post-renal transplant erythrocytosis and microalbuminuria: response to angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

Beta-adrenergic blockade does not prevent polycythemia or decrease in plasma volume in men at 4300 m altitude.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

INTERFERENCE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ON ERYTHROPOIESIS IN KIDNEY TRANSPLANT RECIPIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

The origin of proteinuria at high altitude

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907812-1

7 January 2021

10.1016/S0140-6736(02)07812-1

Identifiers

DOI

1 reference

27 November 2017

1 reference